Such a mechanism has been proposed for the aggravated disease observed in CD73-/- mice in a graft versus host disease model [59] and enhanced anti-graft responses of CD73-/- mice in transplantation models [60, 61]. The gene discussed is NT5E; the disease is glycogen storage disease VI.